<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The concept of synthetic <z:mp ids='MP_0010769'>lethality</z:mp> has gained popularity as a rational guide for predicting chemotherapeutic targets based on negative genetic interactions between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> and a second-site target gene </plain></SENT>
<SENT sid="1" pm="."><plain>One hallmark of most <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> that can be exploited by chemotherapies is chromosome instability (CIN) </plain></SENT>
<SENT sid="2" pm="."><plain>Because chromosome replication, maintenance, and segregation represent conserved and cell-essential processes, they can be modeled effectively in simpler eukaryotes such as Saccharomyces cerevisiae </plain></SENT>
<SENT sid="3" pm="."><plain>Here we analyze and extend genetic networks of CIN <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> gene orthologs in yeast, focusing on essential genes </plain></SENT>
<SENT sid="4" pm="."><plain>This identifies hub genes and processes that are candidate targets for synthetic lethal killing of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells with defined <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>One hub process in these networks is DNA replication </plain></SENT>
<SENT sid="6" pm="."><plain>A nonessential, fork-associated scaffold, CTF4, is among the most highly connected genes </plain></SENT>
<SENT sid="7" pm="."><plain>As Ctf4 lacks enzymatic activity, potentially limiting its development as a therapeutic target, we exploited its function as a physical interaction hub to rationally predict synthetic lethal interactions between essential Ctf4-binding proteins and CIN <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> gene orthologs </plain></SENT>
<SENT sid="8" pm="."><plain>We then validated a subset of predicted genetic interactions in a human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell line, showing that siRNA-mediated knockdown of MRE11A sensitizes cells to <z:mpath ids='MPATH_63'>depletion</z:mpath> of various replication fork-associated proteins </plain></SENT>
<SENT sid="9" pm="."><plain>Overall, this work describes methods to identify, predict, and validate in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells candidate therapeutic targets for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with known <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in CIN genes using data from yeast </plain></SENT>
<SENT sid="10" pm="."><plain>We affirm not only replication stress but also the targeting of DNA replication fork proteins themselves as potential targets for anticancer therapeutic development </plain></SENT>
</text></document>